Myriad Genetics | MYGN - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Danaher USD 1.34B 158M 2026-03
Illumina USD 239M 17M 2026-03
J&J USD 6.62B 1.03B 2026-03
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -31.8M 5.5M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Waters USD 148M 122.52M 2026-03